Veröffentlichungsdatum: 23 November 2020
Projektträger – zwischengeschaltetes Finanzinstitut
GRUPO FERRER INTERNACIONAL SA
The project covers the Promoter's research and development (R&D) activities in a number of well-defined therapeutic areas.
The EIB loan will be used to finance R&D and deployment investments supporting the implementation of the company's strategy. The investments are expected to support the Promoter's competitiveness and growth.
- Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 50 million
Gesamtkosten (voraussichtlicher Betrag)
EUR 104 million
The project concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
The Promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, and is thus not subject to EU rules on public procurement.
Unterzeichnet - 11/12/2020
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).